title: The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity.
abstract: The early steps of the hepatitis B virus (HBV) life cycle are still poorly understood. Indeed, neither the virus receptor at the cell surface nor the mechanism by which nucleocapsids are delivered to the cytosol of infected cells has been identified. Extensive mutagenesis studies in pre-S1, pre-S2, and most of the S domain of envelope proteins revealed the presence of two regions essential for HBV infectivity: the 77 first residues of the pre-S1 domain and a conformational motif in the antigenic loop of the S domain. In addition, at the N-terminal extremity of the S domain, a putative fusion peptide, partially overlapping the first transmembrane (TM1) domain and preceded by a PEST sequence likely containing several proteolytic cleavage sites, was identified. Since no mutational analysis of these two motifs potentially implicated in the fusion process was performed, we decided to investigate the ability of viruses bearing contiguous deletions or substitutions in the putative fusion peptide and PEST sequence to infect HepaRG cells. By introducing the mutations either in the L and M proteins or in the S protein, we demonstrated the following: (i) that in the TM1 domain of the L protein, three hydrophobic clusters of four residues were necessary for infectivity; (ii) that the same clusters were critical for S protein expression; and, finally, (iii) that the PEST sequence was dispensable for both assembly and infection processes.
authors.affiliation: Institut National de la Santé Et de la Recherche Médicale, Unité 522, Rennes, France.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Lepère-Douard
authors.forename: Maud
authors.initials: M
authors.lastname: Trotard
authors.forename: Jacques
authors.initials: J
authors.lastname: Le Seyec
authors.forename: Philippe
authors.initials: P
authors.lastname: Gripon
mesh_terms: D045744:Cell Line, Tumor; D006509:Hepatitis B / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000502:physiology; D006513:Hepatitis B e Antigens / Q000502:physiology; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D016297:Mutagenesis, Site-Directed; D014759:Viral Envelope Proteins / Q000502:physiology*
chemical_list: D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; C096362:L protein, hepatitis B virus; C118669:S envelope protein, hepatitis B virus; D014759:Viral Envelope Proteins